Simplify Logo

Full-Time

Chief Commercial Officer

Confirmed live in the last 24 hours

ArteraAI

ArteraAI

11-50 employees

Personalizes prostate cancer therapy using deep learning

Hardware
AI & Machine Learning
Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Strategy Development
Business Development
Business & Strategy
Required Skills
Market Research
Sales
Communications
Mergers & Acquisitions (M&A)
Marketing
Requirements
  • Substantial experience in developing commercial strategies and building teams across multiple oncological disease sites and product lines (high priority).
  • Substantial experience bringing to market lab-developed tests and medical software or IVDs, with a proven track record of driving sales from <$10M to >$50M+ in ARR or similar (high priority).
  • Proven track record of success in senior leadership roles, with extensive experience in sales, marketing, reimbursement, and business development in the healthcare industry.
  • Experience negotiating contracts with commercial partners.
  • Experience driving commercial success at fast-growth startups, specifically in regulated healthcare markets.
  • Ability to effectively function as a player-coach, working across the spectrum of very small to very large teams.
  • Strong strategic thinking and analytical skills, with the ability to translate market insights into actionable plans.
  • Excellent communication, negotiation, and interpersonal skills, with the ability to build rapport with clients and internal stakeholders.
  • Demonstrated leadership abilities, with a focus on coaching, mentoring, and inspiring teams to achieve exceptional results.
  • Experience with oncology and biomarkers is required.
Responsibilities
  • Develop and execute a comprehensive commercial strategy across multiple oncological product lines and solid tumors. Drive revenue growth, national and international market expansion, and customer acquisition through innovative approaches.
  • Build, lead, and mentor a high-performing commercial team, including sales, marketing, reimbursement, and market access. Set clear targets and provide guidance to achieve commercial goals. Implement best practices for sales and marketing processes, pipeline management, and performance metrics. Balance the need to build a lean team at a fast-growing startup with the need to hire expertise across multiple disease sites.
  • Identify and pursue new business opportunities, partnerships, and revenue streams. Foster relationships with key clients, stakeholders, and industry partners to drive business growth and ensure customer satisfaction. Analyze and offer creative strategies to introduce Artera products to ex-US markets. These include partnerships with health systems, large clinician group practices, pharmaceutical companies, payers, and any third party entities whose products or technologies would enhance the Artera offering.
  • Conduct market research and analysis to identify trends, competitive landscape, and customer needs. Utilize insights to refine and enhance product offerings, pricing strategies, and go-to-market plans.
  • Collaborate closely with, and support, other departments, including operations, product, medical affairs, regulatory, and clinical development to align commercial efforts with overall business objectives. Champion a culture of teamwork and collaboration across the organization.
  • Build a system to monitor KPIs, sales forecasts, and financial targets to measure performance and identify areas for improvement. Implement effective reporting mechanisms to track progress and provide regular updates to the executive team.
  • Assess and mitigate risks related to commercial operations, pricing, contracts, and market fluctuations. Ensure compliance with relevant regulations and industry standards.

ArteraAI focuses on personalizing therapy for prostate cancer through its main product, the ArteraAI Prostate Test, which is a clinical laboratory test developed in-house. This test utilizes advanced multi-modal deep learning techniques to analyze patient data and provide tailored treatment options. Unlike many competitors, ArteraAI's test is not experimental; it is used in actual clinical settings, ensuring reliability and effectiveness. The company serves healthcare providers, hospitals, and individual patients, generating revenue through the sale of their prostate test. ArteraAI stands out in the healthcare technology market due to its commitment to scientific rigor, as demonstrated by its reliance on randomized phase III clinical trials, and its CLIA certification, which enhances its credibility. The goal of ArteraAI is to improve prostate cancer treatment outcomes by offering personalized therapy options and continuously advancing their technology through research and development.

Company Stage

Series C

Total Funding

$110M

Headquarters

Menlo Park, California

Founded

2021

Growth & Insights
Headcount

6 month growth

8%

1 year growth

30%

2 year growth

74%
Simplify Jobs

Simplify's Take

What believers are saying

  • ArteraAI's recent $20 million funding round from prominent investors supports its mission to advance personalized cancer therapy and expand internationally.
  • Partnerships with organizations like Movember and GenesisCare enhance ArteraAI's credibility and broaden its impact in the global healthcare community.
  • Inclusion in the NCCN Guidelines and Medicare approval for the ArteraAI Prostate Test ensures broader accessibility and recognition in the medical community.

What critics are saying

  • The highly specialized focus on prostate cancer may limit market size and growth potential compared to companies with a broader oncology focus.
  • Reliance on continuous validation and clinical trials could delay product updates and market expansion.

What makes ArteraAI unique

  • ArteraAI leverages advanced multi-modal deep learning techniques to personalize prostate cancer therapy, setting it apart from traditional treatment methods.
  • The ArteraAI Prostate Test is the first AI-enabled predictive and prognostic test included in the NCCN Guidelines for localized prostate cancer, highlighting its clinical validation and reliability.
  • Their focus on high complexity clinical laboratory tests, backed by randomized phase III clinical trials, ensures a high level of scientific rigor and reliability.